Kamada KMDA
NASDAQ KMDA
$8.23 +0.03 (+0.37%)
As of: Oct 2, 2026 · 9:58 AM EDT

Kamada (KMDA) Invested Capital (2012 - 2026)

Updated

Kamada's Invested Capital came in at $275.59 million for the quarter ended Jun 30, 2026, up 2.1% from $269.8 million a year earlier and up 2.1% from the prior quarter.

Analysis

Kamada (KMDA) Invested Capital (2012 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Kamada's Invested Capital was $278.99 million, up 3.5% from the prior year.

  • Invested Capital has increased in each of the last nine years, with a five-year compound annual growth rate of 9.3% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Invested Capital was $269.65 million in the year ended Dec 31, 2024 (+4.1%), $259.02 million in the year ended Dec 31, 2023 (+23.2%), $210.17 million in the year ended Dec 31, 2022 (+7.9%) and $194.81 million in the year ended Dec 31, 2021 (+8.9%).
  • The five-year range for quarterly Invested Capital is $20.29 million (the quarter ended Jun 30, 2022) to $278.99 million (the quarter ended Dec 31, 2025).
  • Year-over-year, Invested Capital has increased for five consecutive quarters, with growth averaging 2.8% over the last eight quarters.
  • The fastest year-over-year change in Invested Capital over five years came in the quarter ended Jun 30, 2023 (growth of 969.6%), and the weakest in the quarter ended Jun 30, 2022 (a decline of 88.9%).
  • Business Quant data shows KMDA's Invested Capital at $270.03 million (quarter ended Mar 31, 2026), $278.99 million (quarter ended Dec 31, 2025) and $275.82 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn 275.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 275.59 Mn
Mar 31, 2026 270.03 Mn
Dec 31, 2025 278.99 Mn
Sep 30, 2025 275.82 Mn
Jun 30, 2025 269.80 Mn
Mar 31, 2025 262.85 Mn
Dec 31, 2024 269.65 Mn
Sep 30, 2024 264.75 Mn
Jun 30, 2024 263.76 Mn
Mar 31, 2024 264.13 Mn
Dec 31, 2023 259.02 Mn
Sep 30, 2023 254.38 Mn
Jun 30, 2023 217.01 Mn
Mar 31, 2023 204.24 Mn
Dec 31, 2022 210.17 Mn
Sep 30, 2022 197.65 Mn
Jun 30, 2022 20.29 Mn
Mar 31, 2022 194.25 Mn
Dec 31, 2021 194.81 Mn
Sep 30, 2021 181.67 Mn
API Access

Kamada Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=KMDA&period=max&api_key=YOUR_API_KEY